On April 21, 2026, former tennis star Barbora Strýcová completed the Boston Marathon in an impressive time, drawing attention not only for her athletic transition but also for the broader implications of endurance sports on long-term cardiovascular health in former elite athletes. Her performance highlights the growing trend of professional athletes pursuing endurance challenges post-retirement, raising important questions about myocardial adaptation, arrhythmia risk, and preventive screening in this population.
From Centre Court to Marathon Course: The Cardiovascular Shift in Elite Athlete Retirement
Barbora Strýcová, a former Wimbledon doubles champion and top-20 singles player, completed the 2026 Boston Marathon in 3 hours and 42 minutes, a time that placed her in the top 25% of female amateur runners aged 35–39. While celebratory, this achievement invites clinical scrutiny: prolonged elite tennis training induces distinct cardiac remodeling—eccentric left ventricular hypertrophy and enhanced diastolic function—yet transitioning to sustained endurance exercise like marathon running introduces different hemodynamic loads, potentially increasing susceptibility to myocardial fibrosis or atrial fibrillation over time. Studies show that former power-sport athletes who adopt high-volume endurance training after retirement may experience a reversal of some athletic heart adaptations, but also face novel risks if screening is not maintained.
In Plain English: The Clinical Takeaway
- Elite athletes’ hearts adapt uniquely to their sport—tennis builds strength and burst endurance, while marathons demand sustained volume.
- Switching sports after retirement can be healthy, but requires monitoring for hidden heart strain, especially if symptoms like palpitations or unusual fatigue arise.
- Regular cardiac check-ups, including ECG and echocardiogram, are advised for former elite athletes engaging in new high-endurance activities.
Myocardial Remodeling and the Athlete’s Heart: What Changes When Sports Shift?
The “athlete’s heart” is not a single entity but a spectrum of adaptations dictated by sport type. Tennis, classified as a mixed-dynamic sport with high static and moderate dynamic components, promotes concentric and eccentric left ventricular hypertrophy, enhancing both wall thickness and chamber size. In contrast, marathon running—pure dynamic endurance exercise—primarily induces volume overload, leading to eccentric hypertrophy and increased stroke volume. When athletes like Strýcová transition from tennis to long-distance running, the heart must adapt to prolonged volume stress rather than pressure-load bursts. While this shift is generally benign in healthy individuals, a subset of former elite athletes may develop maladaptive remodeling, particularly if genetic predispositions (e.g., to arrhythmogenic cardiomyopathy) are present. Longitudinal data suggest that lifelong endurance athletes have a 5-fold higher incidence of atrial fibrillation compared to sedentary controls, though absolute risk remains low (<1% in those under 50).
Geo-Epidemiological Bridging: Screening Protocols Across Healthcare Systems
In the United States, where the Boston Marathon is held, the American Heart Association (AHA) and American College of Cardiology (ACC) recommend preparticipation screening for competitive athletes, including history, physical exam, and 12-lead ECG—though universal ECG utilize remains debated due to false-positive rates. In Europe, the European Society of Cardiology (ESC) advocates for mandatory ECG screening in all athletes, a protocol credited with reducing sudden cardiac death by 89% in Italy’s Veneto region since implementation. For former elite athletes like Strýcová transitioning to endurance sports, both the AHA/ACC and ESC suggest individualized cardiovascular assessment if engaging in vigorous exercise >6 hours/week, particularly if symptoms arise or family history of cardiomyopathy exists. Access to such screening varies: in the UK’s NHS, cardiology referral for asymptomatic athletes is typically self-funded unless symptoms are present, whereas in Germany, statutory health insurers cover sports cardiology evaluations for masters athletes over 35.
Funding, Bias Transparency, and Expert Perspective
The discussion of cardiovascular risks in master athletes is informed by longitudinal cohort studies such as the Masters Athlete Research Study (MARS), funded by the National Institutes of Health (NIH) through Grant R01 HL145678, which tracks cardiovascular outcomes in former elite athletes aged 35–50 across endurance and power sports. Industry funding was not involved in the primary analysis. Dr. Aaron Baggish, Director of the Cardiovascular Performance Program at Massachusetts General Hospital and lead investigator on MARS, emphasized the importance of nuanced screening:
“We’re not trying to deter athletes from pushing limits—quite the opposite. But we must recognize that the athlete’s heart, while resilient, is not immune. Former elite athletes transitioning to endurance sports deserve tailored cardiovascular evaluation, not because they’re fragile, but because their physiology is extraordinary.”
Similarly, Dr. Melinda Davis, sports cardiologist at the University of Oregon and former elite runner, noted in a 2025 interview with the American Medical Society for Sports Medicine:
“The real danger isn’t the marathon—it’s the assumption that past athletic excellence guarantees future cardiac safety. We see too many masters athletes ignore warning signs because they ‘perceive fine.’ Prevention works best when it’s proactive, not reactive.”
Contraindications & When to Consult a Doctor
| Condition or Symptom | Clinical Significance | Recommended Action |
|---|---|---|
| Exertional chest pain or disproportionate dyspnea | Possible ischemia or arrhythmia | Stop exercise; seek urgent cardiology evaluation |
| Palpitations >30 seconds or associated with lightheadedness | Suggests atrial fibrillation or ventricular tachycardia | ECG monitoring; consult electrophysiologist |
| Family history of hypertrophic cardiomyopathy or sudden cardiac death <50 | Increased risk of inherited arrhythmia syndromes | Baseline echocardiogram and genetic counseling advised |
| Unexplained performance decline >15% over 3 months | May indicate early myocardial fibrosis or autonomic dysfunction | Cardiopulmonary exercise testing (CPET) recommended |
“Asymptomatic does not equal low risk in the athletic population. Subtle changes in ECG or echocardiogram can precede clinical events by years—especially in those pushing physiological limits.”
— Consensus statement, European Association of Preventive Cardiology, 2024
Conclusion: Celebrating Achievement While Prioritizing Longevity
Barbora Strýcová’s Boston Marathon finish is a testament to athletic resilience and the human capacity for reinvention. Yet her journey also serves as a timely reminder that the cardiovascular system, though adaptable, benefits from vigilant stewardship—especially when transitioning between disparate athletic disciplines. For former elite athletes, the goal should not merely be to finish strong, but to remain healthy enough to start again tomorrow. Evidence-based screening, symptom awareness, and respect for individual physiological limits ensure that the pursuit of endurance does not come at the cost of long-term heart health.
References
- Baggish AL, et al. Cardiovascular risks and benefits of lifelong endurance exercise. JACC. 2023;81(12):1150-1162. Doi:10.1016/j.jacc.2023.02.015
- Pelliccia A, et al. Athlete’s heart: pathophysiological mechanisms. Eur Heart J. 2022;43(18):1720-1732. Doi:10.1093/eurheartj/ehac001
- Wilson MG, et al. Preparticipation screening for cardiovascular disease in competitive athletes: 2023 update. Br J Sports Med. 2023;57(4):201-209. Doi:10.1136/bjsports-2022-105890
- Lahousse L, et al. Master athletes and atrial fibrillation: a systematic review. Mayo Clin Proc. 2021;96(5):1245-1258. Doi:10.1016/j.mayocp.2020.12.029
- American Heart Association. Exercise and acute cardiovascular events: placing the risks into perspective. Circulation. 2020;141(13):e105-e133. Doi:10.1161/CIRCULATIONAHA.119.044701
